The oncology landscape is undergoing a monumental shift from invasive tissue biopsies to minimally invasive diagnostics. At the heart of this revolution is the Circulating Tumor Cells (CTC) Liquid Biopsy Market. By isolating and analyzing malignant cells that have shed from a primary tumor into the bloodstream, CTC technology provides a real-time, "living" snapshot of a patient’s canc... https://www.databridgemarketresearch.com/